
13.95 Delayed Data As of 4:00pm ET | ![]() Today’s Change | 13.05 Today|||52-Week Range 17.31 | +2.35% Year-to-Date |
TAK vs. ZTS: Which Stock Should Value Investors Buy Now? Aug 03 / Zacks.com - Paid Partner Content | Wall Street Analysts See a 26% Upside in Takeda Pharmaceutical Co. (TAK): Can the Stock Really Move This High? Aug 02 / Zacks.com - Paid Partner Content |
Previous close | 13.84 |
Today’s open | 13.91 |
Day’s range | 13.89 - 14.02 |
Volume | 2,127,589 |
Average volume (3 months) | 2,646,111 |
Market cap | $42.8B |
Earnings growth (last year) | -42.31% |
Earnings growth (this year) | +28.48% |
Earnings growth (next 5 years) | +17.50% |
Revenue growth (last year) | +5.34% |
P/E ratio | 29.9 |
Price/Sales | 1.42 |
Price/Book | 0.92 |
Next reporting date | October 27, 2022 |
EPS forecast (this quarter) | $0.14 |
Annual revenue (last year) | $31.8B |
Annual profit (last year) | $2.0B |
Net profit margin | 6.45% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Osaka, Osaka |